search:

Natural Therapy] NEWS: INS-1

From: chris (anonymous@obgyn.net)
Fri, 26 Jan 2001 13:22:31 +0800


>
>INS-1 LOOKS VERY PROMISING IN PHASE II TRIALS
>
>(MEDSCAPE, JANUARY 16, 2001) - Full analysis of a phase II clinical
>trial shows that an experimental thiazolidinedione, INS-1, shows
>promise for the treatment of type 2 diabetes, especially in patients
>with milder disease.
>
>Insmed, Inc. is developing the drug, currently called INS-1, for
>treatment of type 2 diabetes and polycystic ovary syndrome. INS-1
>acts by replacing the molecule d-chiro-inositol, a mediator of
>insulin signaling, thereby sensitizing cells to insulin action.
>
>"Clearly, we are very pleased with the outcome of this clinical
>study, " said Dr. Geoffrey Allan, CEO and president of Insmed, Inc.
>"We would expect to have phase III trials completed and a New Drug
>Application to the US Food and Drug Administration submitted in the
>year 2004."
>
>For the Full Press Release text, log on to Medscape and this URL
>(must have a free Medscape login & password):
>
>http://diabetes.medscape.com/32177.rhtml?srcmp=endo-011201
>
>~~~~~~~~~~~~~~~~~~
>Director of Media Relations
>Polycystic Ovarian Support Association, Inc. (PCOSA)
>pr@pcosupport.org

_________________________________________________________________________ Get Your Private, Free E-mail from MSN Hotmail at http://www.hotmail.com.

--
_________________________________________________________________________



recommended search...
Google
OBGYN.net forums endometriosis zone Web

use when must restrict search to only the pcos forum...
Enter search keywords:
Returns per screen: Require all keywords:
Return to [ PCOS Discussion Forums ] Technical Problems: webmaster@obgyn.net
Last Updated: Mon May 19 16:55:44 2008

Women's Insurance Checklist from Auto Insurance Quote

home | medical professionals | women | industry | forums | international
e-mail | about us | advertising | our sponsors | contact us | disclaimer |

This information is provided for educational purposes only.
Please read the disclaimer. ©1996-2008, all rights reserved.
Do not reproduce without permission of MediSpecialty.com